
Welcome
Welcome to the Echosens Clinical Library, the database to find the most relevant clinical evidences in the field of hepatology related to FibroScan® and FibroMeter®.
AFEF guidelines
2018
Ultrasound in Medicine and Biology 41, 5 (1161-1179)
Discordance in steatosis classification between liver biopsy and transient elastography for high controlled attenuation parameter (CAP) values
2018
Zeitschrift für Gastroenterologie 56;1 (36-42)
Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study
Hui R. W. H., Seto W. K., Cheung K. S., Mak L. Y., Liu K. S. H., Fung J., Wong D. K., Lai C. L. and Yuen M. F.
2018
Journal of viral hepatitis 25;1 (97-104)
Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b
Ogasawara N., Kobayashi M., Akuta N., Kominami Y., Fujiyama S., Kawamura Y., Sezaki H., Hosaka T., Suzuki F., Saitoh S., Suzuki Y., Arase Y., Ikeda K., Kobayashi M. and Kumada H.
2018
Journal of Medical Virology 90;2 (313-319)
Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity
Ooi G. J., Earnest A., Kemp W. W., Burton P. R., Laurie C., Majeed A., Johnson N., McLean C., Roberts S. K. and Brown W. A.
2018
International journal of obesity In Press;
Effect of Treatment with Direct Acting Antivirals on Body Mass Index and Hepatic Steatosis in Chronic Hepatitis C
Shousha H. I., Abdelaziz R. A., Azab S. M., Khairy M., Afifi S. A., Mehrez M. I., Eshra M. A. and Abdelrahim A. Y.
2018
Journal of Medical Virology In Press;
Controlled Attenuation Parameter And Alcoholic Hepatic Steatosis: Diagnostic Accuracy and Role Of Alcohol Detoxification
Thiele M., Rausch V., Fluhr G., Kjaergaard M., Piecha F., Piecha F., Mueller J., Straub B. K., Lupsor-Platon M., De-Ledinghen V., Seitz H. K., Detlefsen S., Detlefsen S., Madsen B., Krag A. and Mueller S.
2018
Journal of Hepatology In Press;
Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography
2018
Clinics in liver disease 22;1 (73-92)
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease
Vuppalanchi R., Siddiqui M. S., Van Natta M. L., Hallinan E., Brandman D., Kowdley K., Neuschwander-Tetri B. A., Loomba R., Dasarathy S., Abdelmalek M., Doo E., Tonascia J. A., Kleiner D. E., Sanyal A. J. and Chalasani N.
2018
Hepatology 67;1 (134-144)
Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease
2018
European Journal of Gastroenterology & Hepatology 30;2 (207-211)
Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
Anadol E., Lust K., Boesecke C., Boesecke C., Schwarze-Zander C., Mohr R., Mohr R., Wasmuth J. C., Wasmuth J. C., Rockstroh J. K. and Trebicka J.
2018
PLoS ONE 13;1 (e0191118)
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J., Valli P. V., Bergamin I., Kroger A., Kunzler P., Baserga A., Braun D. L., Seifert B., Moncsek A., Fehr J., Semela D., Magenta L., Mullhaupt B., Terziroli Beretta-Piccoli B., Mertens J. and The Swiss Hepatitis C. C. S.
2018
Swiss Medical Weekly 148;(w14560)
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease
Bellan M., Sainaghi P. P., Minh M. T., Minisini R., Molinari L., Baldrighi M., Salmi L., Barbaglia M. N., Castello L. M., Ravanini P., Avanzi G. C. and Pirisi M.
2018
Biomark Med 12;1 (27-34)
Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation
2018
Digestive & Liver Disease 50;1 (54-60)
High Prevalence of Liver Fibrosis Among European Adults with Unknown Liver Disease. A Population-Based Study
Caballeria L., Caballeria L., Pera G., Arteaga I., Rodriguez L., Aluma A., Morillas R. M., de la Ossa N., Diaz A., Exposito C., Miranda D., Sanchez C., Prats R. M., Urquizu M., Salgado A., Alemany M., Martinez A., Majeed I., Fabrellas N., Graupera I., Planas R., Ojanguren I., Ojanguren I., Serra M., Toran P., Caballeria J. and Gines P.
2018
Clinical Gastroenterology & Hepatology In Press;
Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection
2018
Journal of gastroenterology and hepatology 33;1 (256-263)
Persistence of hepatocellular carcinoma risk in hepatitis c patients with a response to ifn and cirrhosis regression
D'Ambrosio R., Aghemo A., Rumi M. G., Degasperi E., Sangiovanni A., Maggioni M., Fraquelli M., Perbellini R., Rosenberg W., Bedossa P., Colombo M. and Lampertico P.
2018
Liver International In Press;
Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients
Gamil M., Alboraie M., El-Sayed M., El-Sayed M., Elsharkawy A., Asem N., Asem N., Elbaz T., Elbaz T., Mohey M., Abbas B., Mehrez M. and Esmat G.
2018
Journal of Medical Virology In Press;
Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study
Hui R. W. H., Seto W. K., Cheung K. S., Mak L. Y., Liu K. S. H., Fung J., Wong D. K., Lai C. L. and Yuen M. F.
2018
Journal of viral hepatitis 25;1 (97-104)
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease
2018
Hepatology International In Press;
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)
2017
BMC Gastroenterology 15;1 (183)
American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis
2017
BMC Gastroenterology 15;1 (183)
Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection
Couto I., Victoria M., Veloso V. G., Veloso V. G., Rodrigues L., Grinsztejn B., Grinsztejn B., Lacerda M., Victoria F. and Perazzo H.
2017
PLoS ONE 12;3 (e0174453)
Noninvasive Evaluation of Portal Hypertension Using a Supervised Learning Technique
2017
J Healthc Eng 2017;(6183714)
Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals
Pons M., Pons M., Santos B., Santos B., Simon-Talero M., Simon-Talero M., Ventura-Cots M., Ventura-Cots M., Riveiro-Barciela M., Esteban R., Augustin S. and Genesca J., Augustin S. and Genesca J.
2017
Therapeutic Advances in Gastroenterology 10;8 (619-629)
Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis
Veiga Z. S. T., Villela-Nogueira C. A., Villela-Nogueira C. A., Fernandes F. F., Cavalcanti M. G., Figueiredo F. A., Pereira J. L., Pereira G. H., Moraes Coelho H. S., Peralta J. M., Marques C. E., Perez R. M. and Fogaca H. S.
2017
European Journal of Gastroenterology & Hepatology 29;6 (730-735)
A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial
Wong G. L. H., Kwok R., Hui A. J., Tse Y. K., Tse Y. K., Ho K. T., Lo A. O. S., Lam K. L. Y., Chan H. C. H., Lui R. A., Au K. H. D., Chan H. L. Y. and Wong V. W. S.
2017
Liver International In Press;
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by Fibroscan in non-alcoholic fatty liver disease
Boursier J., Vergniol J., Guillet A., Hiriart J. B., Lannes A., Le Bail B., Michalak S., Chermak F., Bertrais S., Foucher J., Oberti F., Charbonnier M., Fouchard-Hubert I., Rousselet M. C., Cales P. and de Ledinghen V.
2016
Journal of Hepatology In press;
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy
Cassinotto C., Boursier J., de Ledinghen V., Lebigot J., Lapuyade B., Cales P., Hiriart J. B., Michalak S., Bail B. L., Cartier V., Mouries A., Oberti F., Fouchard-Hubert I., Vergniol J. and Aube C.
2016
Hepatology 63;6 (1817-1827)
Critical comparison of elastography methods to assess chronic liver disease
2016
Nature reviews. Gastroenterology & hepatology 13;7 (402-411)
Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis
Fujimori N., Tanaka N., Shibata S., Sano K., Yamazaki T., Sekiguchi T., Kitabatake H., Ichikawa Y., Kimura T., Komatsu M., Umemura T., Matsumoto A. and Tanaka E.
2016
Hepatology Research In press;
Noninvasive assessment of liver stiffness by transient elastography (FibroScan) in liver fluke disease
2016
European Journal of Gastroenterology & Hepatology 28;1 (70-73)
Evaluation of Histological and non-Invasive Methods for the Detection of Liver Fibrosis: The Values of Histological and Digital Morphometric Analysis, Liver Stiffness Measurement and APRI Score
Halasz T., Horvath G., Kiss A., Par G., Szombati A., Gelley F., Nemes B., Kenessey I., Piurko V. and Schaff Z.
2016
Pathology oncology research 22;1 (1-6)
Nonalcoholic fatty liver disease and elastography: Incremental advances but work still to be done
2016
Hepatology 63;6 (1762-1764)
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Digestive Diseases & Sciences 61;5 (1356-1364)
Association Between Level of Fibrosis, Rather than Antiviral Regimen, and Outcomes of Patients with Chronic Hepatitis B
Kim H. S., Kim B. K., Kim S. U., Park J. Y., Kim D. Y., Song K. J., Park J. W., Kim Y. J., Baatarkhuu O., Han K. H. and Ahn S. H.
2016
Clinical Gastroenterology & Hepatology In press;
Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
Kim J. M., Ha S. Y., Joh J. W., Sinn D. H., Jeong W. K., Choi G. S., Gwak G. Y., Kwon C. H., Kim Y. K., Paik Y. H., Lee J. H., Lee W. J., Lee S. K. and Park C. K.
2016
Medicine (Baltimore) 95;7 (e2718)
Hepatic hydrothorax without ascites as the first sign of liver cirrhosis
2016
Respirology Case Reports 4;1 (16-18)
Advances in the treatment of portal hypertension in cirrhosis
2016
Expert Review of Gastroenterology & Hepatology 10;8 (961-969)
HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes
2016
Hepatology International In press;
Combined detection of liver stiffness and C-reactive protein in patients with hepatitis B virus-related liver cirrhosis, with and without hepatocellular carcinoma
2016
Molecular and Clinical Oncology 4;4 (587-590)
Liver fibrosis and fatty liver in Asian HIV-infected patients
Lui G., Wong V. W., Wong G. L., Chu W. C., Wong C. K., Yung I. M., Wong R. Y., Yeung S. L., Yeung D. K., Cheung C. S., Chan H. Y., Chan H. L. and Lee N.
2016
Alimentary Pharmacology & Therapeutics 44;4 (411-421)
The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter
Chon Y. E., Kim K. J., Jung K. S., Kim S. U., Park J. Y., Kim do Y., Ahn S. H., Chon C. Y., Chung J. B., Park K. H., Bae J. C. and Han K. H.
2016
Yonsei Medical Journal 57;4 (885-892)
Adaptation of liver stiffness measurement depth in bariatric surgery candidates with suspected nonalcoholic fatty liver disease
Ciocan D., Lebrun A., Lamouri K., Pourcher G., Voican C., Njike-Nakseu M., Ferretti S., Courie R., Tranchart H., Balian A., Prevot S., Perlemuter G., Dagher I. and Naveau S.
2016
European Journal of Gastroenterology & Hepatology 28;9 (1014-1020)
High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262)
Nguyen Truong T., Laureillard D., Lacombe K., Duong Thi H., Pham Thi Hanh P., Truong Thi Xuan L., Chu Thi N., Luong Que A., Vu Hai V., Nagot N., Tuaillon E., Dominguez S. and Lemoine M.
2016
PLoS ONE 11;5 (e0153744)
Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment
Nosotti L., Petrelli A., Genovese D., Catone S., Argentini C., Vella S., Rossi A., Costanzo G., Fortino A., Chessa L., Miglioresi L. and Mirisola C.
2016
Journal of Immigrant and Minority Health In press;
Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy
Fitzpatrick J. A., Kim J. U., Cobbold J. F., McPhail M. J., Crossey M. M., Bak-Bol A. A., Zaky A. and Taylor-Robinson S. D.
2016
Journal of Clinical and Experimental Hepatology 6;1 (15-20)
Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP)
2016
Journal of Gastrointestinal & Liver Diseases 25;2 (175-181)
Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy
Saez-Royuela F., Linares P., Cervera L. A., Almohalla C., Jorquera F., Lorenzo S., Garcia I., Karpman G., Badia E., Vallecillo M. A., Moncada A., Calvo S., Olcoz J. L. and Asociacion Castellano y Leonesa de H.
2016
European Journal of Gastroenterology & Hepatology 28;3 (305-312)
Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus
Hollande C., Mallet V., Darbeda S., Vallet-Pichard A., Fontaine H., Verkarre V., Sogni P., Terris B., Gouya H. and Pol S.
2016
Medicine (Baltimore) 95;11 (e3081)
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
Imajo K., Kessoku T., Honda Y., Tomeno W., Ogawa Y., Mawatari H., Fujita K., Yoneda M., Taguri M., Hyogo H., Sumida Y., Ono M., Eguchi Y., Inoue T., Yamanaka T., Wada K., Saito S. and Nakajima A.
2016
Gastroenterology 150;3 (626-637 e627)
A new 3p25 locus is associated with liver fibrosis progression in HIV/HCV co-infected patients
Ulveling D., Le Clerc S., Cobat A., Labib T., Noirel J., Laville V., Coulonges C., Carpentier W., Nalpas B., Heim M. H., Poynard T., Cerny A., Pol S., Bochud P. Y., Dabis F., Theodorou I., Levy Y., Salmon D., Abel L., Dominguez S., Zagury J. F., cohort H. A. C., Swiss Hepatitis C. C. S. G. and French A. H. C. E. P. G. S. G.
2016
Hepatology In press;
Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C
Valcour V. G., Rubin L. H., Obasi M. U., Maki P. M., Peters M. G., Levin S., Crystal H. A., Young M. A., Mack W. J., Cohen M. H., Pierce C. B., Adimora A. A., Tien P. C. and Women's Interagency H. I. V. S. P. T.
2016
Journal of Acquired Immune Deficiency Syndromes 72;3 (266-273)
Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study
van der Voort E. A., Koehler E. M., Nijsten T., Stricker B. H., Hofman A., Janssen H. L., Schouten J. N. and Wakkee M.
2016
Acta dermato-venereologica 96;2 (213-217)
Evaluation of large esophageal varices in cirrhotic patients by transient elastography: a meta-analysis
2016
Revista Española de Enfermedades Digestivas 108;